NCT05335876: Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
- State
- Under way
- Phase
- Phase 3
- People
- 20 taking part
- Started
- 19 Dec 2022
- Primary completion
- 29 Apr 2031
- Arms
- Intravenous (IV) & Intrathecal (IT) Onasemnogene Abeparvovec
- Results
- None posted
- 20 Apr 2022: Trial registered
- 19 Dec 2022: Trial started